Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.65, No.4, p.592-598, 2018 |
||
Title: Adjuvant chemotherapy provided survival benefit for stage T2N0 gastric cancer with high-risk factors | ||
Author: Z. WANG, J. YAN, W. HU, J. ZHANG, B. HUO | ||
Abstract: The value of adjuvant chemotherapy in T2N0 gastric cancer (GC) remains controversial. The aim of this retrospective study is to define a high-risk subgroup of pathological T2N0 GC patients and examine the impact of adjuvant chemotherapy on overall survival (OS). A total of 225 patients underwent R0 resection for T2N0 gastric adenocarcinoma between 2002 and 2012 and 51/225 (22.7%) of these received adjuvant chemotherapy. Multivariate Cox regression identified tumor location in the Upper1/3 of the stomach (peast one of the independent risk factor listed above, and we found that adjuvant chemotherapy significantly improved OS for this subgroup. |
||
Keywords: gastric cancer, adjuvant chemotherapy, prognosis, propensity score matching | ||
Published online: 30-Jul-2018 | ||
Year: 2018, Volume: 65, Issue: 4 | Page From: 592, Page To: 598 | |
doi:10.4149/neo_2018_170620N436 |
||
|
download file |
|